Advanced Biomed Inc. ADVB
1.75 USD -0.40 (-18.79%)
Regular-session close
1.75 0.00 0.00%
After hours · Nov 19, 5:29 PM ET
1.70 Day range 2.15
1.70 52-week range 24.23
- YTD
- -70.03%
- 1 year
- -78.81%
5D -0.03 (-1.33%)
- Market cap
- 2.89M
- EPS (ttm)
- -5.03
- YTD return
- -70.03%
- 1-year return
- -78.81%
- Volume
- 52.59K
- Avg volume
- 91.67K
- Open
- 2.15
- Previous close
- 2.16
- Day's range
- 1.70 – 2.15
- 52-week range
- 1.70 – 24.23
Fundamental scorecard
9 of 25 checks passed on ADVB’s reported financials
9of 25 checks passed
- Value 1 of 5
- Growth 2 of 5
- Profitability 2 of 5
- Financial health 4 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
ADVB Revenue — quarterly 0
ADVB Net income — quarterly -989.05K
ADVB EPS — quarterly -0.60
News
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Intraday Session
Advanced Biomed (NASDAQ:ADVB) and Sphere 3D (NASDAQ:ANY) Financial Review Advanced Biomed Inc. (NASDAQ:ADVB) Shares Shorted: Short Interest Down 39.8% in September
Advanced Biomed Inc. Announces 1 for 20 Share Consolidation
Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary
Advanced Biomed Inc. Announces Launch of A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
Your note
Sign in to keep a note on ADVB — it syncs with the Stock Master app.
